Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will report its ...

Algernon Health Inc. (the “ Company ” or “ Algernon ”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, announces that effective April 21, 2026 its corporate name will ...

Dr. Yerusalem Lanier is preparing to take on the Rock ‘n’ Roll Half Marathon on April 25, 2026, for the second year alongside her daughters and husband. For Dr. Lanier, running has become both a path ...

NKX019 Clinical Program Progress and Upcoming Milestones Following submission of the final amendments to FDA and IRB approvals: Outpatient administration will be enabled for both Ntrust-1 and Ntrust-2 ...

Elion Therapeutics, a biotechnology company dedicated to transforming the treatment of life-threatening fungal infections, today announced the initiation of its Phase 2 clinical trial evaluating ...

NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release first quarter 2026 results on Wednesday, April 29, 2026 ...

Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment ...

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its first quarter 2026 financial results before the ...

Through Wave Life Sciences’ listing on Nasdaq, the majority of the company’s operations, its corporate headquarters, the majority of its operating assets, including its manufacturing and research and ...

Acquired in-process research and development expense for the year ended December 31, 2025 was zero compared to $117.5 million for the comparable period in 2024, recognized related to virology programs ...

Integration of The Sleep Center of Nevada and shift in business model support path to improved revenues, margins and cash flow LITTLETON, Colo., April 15, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, ...

Prior to LumiraDx, Dr. Khan held senior leadership roles at Alere, a global leader in rapid diagnostics acquired by Abbott Laboratories for approximately $5.8 billion USD. At Alere, he provided ...